Local anesthetics have myotoxic effects and inhibit CaATPase activity and Ca transport in skeletal muscles. Such effects have not been fully eluci dated in masticatory muscles. We tested the hypothesis that local anesthetics increase myoplas mic calcium in masticatory muscles by inhibiting CaATPase at a concentration similar to that of dental cartridges. The effects of lidocaine and bupi vacaine on CaATPase from rabbit masseter and medial pterygoid muscles were tested with radioiso topic and colorimetric methods. Bupivacaine had an action similar to that of lidocaine on CaATPase activity, but less effect on calcium transport. The preexposure of the membranes to the anesthetics enhanced the CaATPase activity in the absence of calcium ionophore, supporting their permeabiliz ing effect. The results demonstrate that amidetype anesthetics do not inhibit calcium binding, but do reduce calcium transport and enzyme phosphory lation by ATP, and suggest that the myoplasmic calcium increase induced by lidocaine and bupiva caine might promote masticatory muscle contrac tion and eventual rigidity.
KEY WOrDs: SERCA, masticatory muscles, local anesthetics, lidocaine, bupivacaine. IntrODuctIOn t he sarcoplasmic reticulum CaATPase is a membranebound protein which transports calcium ions from the myoplasm to the reticulum lumen at the expense of ATP hydrolysis, leading to muscle relaxation. It has one high affinity ATP binding site (catalytic site) and two calciumbinding sites (trans port sites) (Clarke et al., 1989) .
A summarized enzymatic cycle of CaATPase (Appendix Fig. 1 , filled lines) has been proposed (Lacapere and Guillain, 1990) . In the clockwise reaction, the enzyme in its E1 form binds 3 calcium ions on the cytoplasmic membrane side (out) with high affinity (step 1) to form the E1Ca2 species. The phosphorylation of the enzyme by ATP (step 2, yielding E1PCa2) drives the movement of calcium to the lowaffinity lumenal sites (in). Calcium is then released into the reticulum lumen (step 3), which favors the hydrolysis of the phosphoenzyme E2P (step 4) to E2, completing the cycle.
Few authors have studied the CaATPase from masticatory muscles (Okabe et al., 1985; Sánchez et al., 2004) . Studies on the effects of dental drugs on the CaATPase from masseter and medial pterygoid muscles have not yet been published. Dental local anesthetics have been reported to inhibit the sarcoplasmic reticulum CaATPase from fast muscles (Suko et al., 1976; Wolosker et al., 1992; Takara et al., 2000 Takara et al., , 2005 .
Microscopic studies have revealed that local anesthetics can cause ultra structural damage in muscle fibers (Benoit and Belt, 1970; Dolwick et al., 1977; Yagiela et al., 1981) . Such damage has been attributed to the increase in intracellular Ca 2+ , which might derive from CaATPase dysfunction (Zink et al., 2003) . The likely link between the sarcoplasmic reticulum CaATPase function and the myotoxicity of dental local anesthetics motivated this study. We tested the hypothesis that local anesthetics increase the myoplasmic cal cium in masticatory muscles by inhibiting CaATPase at a concentration similar to that of dental cartridges.
MAtErIAls & MEthODs
Masseter and medial pterygoid muscles were sampled from adult New Zealand rabbits (6 mos old, males, 2 kg) according to previously published methods (Widmer et al., 1997) . The animal use protocol was approved by the Ethics Commission, Faculty of Dentistry, University of Buenos Aires. Sarcoplasmic reticulum membranes were isolated as sealed vesicles accord ing to Champeil et al. (1985) . The protein concentration was measured by the Lowry method (Lowry et al., 1951) .
For Cadependent ATPase activity determinations, sarcoplasmic reticulum membranes (0.1 mg protein/mL) were incubated at 37°C for 2 min in 50 local Anesthetics Inhibit ca-AtPase in Masticatory Muscles rEsEArch rEPOrts biological mmol/L MOPS (3[Nmorpholino] propanesulfonic acid)Tris (Tris[hydroxymethyl]aminomethane) buffer (pH 7.2), 3 mmol/L ATP, 100 mmol/L KCl, 3 mmol/L MgCl 2 , 0.1 mmol/L CaCl 2 , 0.1 mmol/L EGTA (ethyleneglycolbis (βaminoethyl ether)N,N′ tetraacetic acid), 10 μmol/L calcimycin (calcium ionophore A23187) when included, and lidocaine or bupivacaine as indi cated. Reactions were stopped with 5% trichloroacetic acid (final concentration). Because the accumulation of Ca inside the vesicles inhibits CaATPase activity, the Ca ionophore calcimy cin was included in the media to dissipate the Ca gradient gener ated by the pump. The denatured membranes were precipitated by centrifugation. [P i ] was measured in the supernatants (Baginski et al., 1967) and taken as an index of the ATPase activity. When indicated, prior to incubations, the membranes (0.5 mg protein/mL) were exposed to 21 mmol/L lidocaine or bupivacaine and 50 mmol/L MOPSTris buffer (pH 7.2). Later, the media were diluted 1:5 in solutions without lidocaine or bupivacaine, which yielded concentrations of 4.2 mmol/L. The other reactants reached final concentrations as above. Blanks without sarcoplasmic reticulum membranes were run in parallel and subtracted from the experimental values. Caindependent ATPase activity, measured in the absence of added CaCl 2 , was below 5% of total ATPase activity.
ATPdependent calcium uptake was determined with a radio isotopic technique. Sarcoplasmic reticulum vesicles (0.1 mg protein/mL) were incubated at 37°C for 30 sec in 3 mmol/L ATP, 100 mmol/L KCl, 3 mmol/L MgCl 2 , 0.1 mmol/L ( 45 Ca)CaCl 2 (450 cpm/nmol), 0.1 mmol/L EGTA, and 50 mmol/L MOPS Tris (pH 7.2). Reactions were started by addition of the mem branes and were stopped by filtration (Millipore filters, 0.45 μm pore size, Bedford, MA, USA). Filters were washed with 3 mmol/L LaCl 3 . Radioactivity retained in the filters was mea sured in a liquid scintillation counter. Blanks without ATP were run in parallel and subtracted from the experimental values. To test the effect of lidocaine or bupivacaine, we included them in the media at different concentrations. Their effects were also determined at different free Ca and ATP concentrations. Ca uptake in the first enzyme cycle was determined according to Davidson and Berman (1988) : The vesicles were incubated in the above medium without ATP and with low EGTA concentra tion (0.02 mmol/L). Then, 25 μmol/L ATP and 0.25 mmol/L EGTA (final concentrations) and lidocaine or bupivacaine at different concentrations were added. ATP allowed for the phos phorylation of the enzyme and the transport of calcium already bound to the protein, and EGTA precluded further enzyme cycles by sequestering the activating cation.
For the determination of passive calciumbinding to the enzyme, sarcoplasmic reticulum vesicles (0.2 mg protein/mL) were incubated at room temperature for 30 sec in 50 mmol/L MOPSTris (pH 7.2), 0.1 mmol/L EGTA, and ( 45 Ca)CaCl 2 (450 cpm/nmol) at different concentrations and without or with 30 mmol/L lidocaine or bupivacaine. The media were filtered through Millipore filters, and the radioactivity retained was measured in a liquid scintillation counter. Blanks without sarco plasmic reticulum membranes were run in parallel and sub tracted from the experimental values.
CaATPase activity and Ca uptake were analyzed by simula tion of the kinetics of the CaATPase cycle (Appendix Fig. 1 ) (Hecht et al., 1990) , with 0.1 mg protein/mL, 3 mmol/L ATP, and 0.1 mmol/L Ca. Other simulation parameters were as previ ously described (Alonso and Hecht, 1990) , in accordance with many authors (cf. De Meis, 1981). High and low spontaneous Ca diffusion across the membrane was assumed (Appendix Fig.  1 , dotted line), simulating the presence or absence of calcimy cin, and CaATPase activity and Ca uptake were calculated from the respective results. We adjusted the rate constants of the partial steps to obtain CaATPase activity and Ca uptake comparable with those experimentally obtained in the absence of inhibitors. We used data from 10secondssimulated reac tions, including various concentrations of a local anesthetic interacting with an intermediate of the cycle (Appendix Fig. 1 , dashed line), to calculate the inhibition constants K i (activity) and K i (uptake).
Disodium ATP, calcimycin, lidocaine hydrochloride, bupiva caine hydrochloride, MOPS, and Tris were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All other reagents were analytical grade. ( 45 Ca)CaCl 2 was obtained from New England Nuclear (Boston, MA, USA).
Mean values of the results are given with the standard devia tion (SD). Lidocaine or bupivacaine halfmaximal inhibitory concentrations for CaATPase activity or calcium uptake (K i ) are reported with the SEM and were tested for significance by Student's t test (p < 0.05). Equations were fitted to experimental data as reported by Fraser and Suzuki (1974) . Free calcium concentrations were calculated according to Fabiato and Fabiato (1979) .
rEsults
Lidocaine (Appendix Fig. 2) inhibited CaATPase activity (Fig.  1A) , and bupivacaine (Appendix Fig. 2 ) had a similar effect (Appendix Fig. 4A ).
In enzymatic activity determinations, K i values for lidocaine and bupivacaine were not significantly different (Table) .
The effect of lidocaine or bupivacaine on CaATPase activity did not depend on the membrane protein concentration in the incubation medium (data not shown).
CaATPase activity depended on the preexposure time of the sarcoplasmic reticulum membranes in lidocaine (Fig. 1B) or bupivacaine (Appendix Fig. 4B ). The enzymatic activity appeared inhibited with increased preincubation time when measured in the presence of calcimycin (optimal conditions), whereas it appeared enhanced when measured in the absence of ionophore, a fact attributed to the increased membrane permea bility. These opposing effects tended to equalize ATPase activi ties measured under both conditions as the incubation time approached 40 min. Note that the final lidocaine concentration in Fig. 1B was 4 .2 mmol/L, a concentration without appreciable effect in the absence of preexposure (Fig. 1A) .
Lidocaine and bupivacaine inhibited Ca uptake in a concentrationdependent manner ( Fig. 2A and Appendix Fig.  5A ). Bupivacaine K i was significantly higher than for lidocaine (Table) . K i values for Ca uptake were higher than for CaATPase activity (Table) .
Calcium uptake as a function of free Ca concentration uncov ered a sigmoidal profile corresponding to the calcium activation phenomenon (Fig. 2B ). Lidocaine decreased maximal calcium accumulation, but did not affect calcium affinity. Calcium uptake as a function of ATP concentration showed a progressive and saturating increase of calcium accumulation (Fig. 2C) . With 30 mmol/L lidocaine, the curve showed a similar shape with a considerable decrease in the absolute values. Increasing ATP could not relieve the inhibition by lidocaine or bupicavaine. We studied the effects of the anesthetics on phosphorylation of the enzyme by ATP, analyzing calcium transport during the first enzyme cycle. The results (Fig. 2D) confirmed that lidocaine interfered with the phosphorylation reaction. Calcium binding to the enzyme (Appendix Fig. 1, step 1) was not modified by lido caine (Appendix Fig. 3 ) or by bupivacaine ( Appendix Fig. 6 ). The inhibition by lidocaine and bupivacaine was not competi tive with respect to the specific transport and catalytic sites of the enzyme, as deduced from the Ca or ATP concentration dependence of Ca transport.
The simulations of the transport reaction yielded the evolu tion of the concentrations of all the species of the model. CaATPase activity calculated from the rate of P i production was 235 μmol P i .mg protein −1 .hr −1 in the model, with high Ca diffu sion across the membrane. Ca uptake was 25 nmol.mg protein −1 in the model, with low Ca diffusion, under steadystate condi tions. Both results were in agreement with those experimentally obtained in the absence of added local anesthetics (Figs. 1A,  2A) . The transient evolution of E1PCa2 and E2P species with time depended on the simulated presence or absence of calcimy cin (Figs. 3A, 3B) .
For an inhibitor interacting with E2P species (Appendix Fig.  1 ), K i (app) for CaATPase activity, measured in the presence of calcimycin, was lower than K i (app) for Ca uptake, measured in the absence of calcimycin (Fig. 3C ). When the inhibitor inter acted with E1PCa2 species, the opposite result was obtained (data not shown).
DIscussIOn
Hydrophobic drugs inhibit CaATPase (Sokolove et al., 1986; Michelangeli et al., 1990; MartinezAzorin et al., 1992; Caravaca et al., 1995; Takara et al., 2000 Takara et al., , 2005 . Here we report that lidocaine and bupivacaine inhibited the CaATPase activity in sarcoplasmic reticulum membranes from masseter and medial pterygoid muscles. The CaATPase activity was affected by the previous exposure of the sarcoplasmic reticulum membranes to lidocaine or bupivacaine. This demonstrated the dual effect of the local anesthetic. Lidocaine and bupivacaine inhibited the optimal CaATPase activity measured in the presence of calci mycin. In contrast, in the absence of ionophore, lidocaine and bupivacaine increased the membrane permeability, thus enhanc ing the ATPase activity by precluding the inhibitory effect of intravesicular Ca accumulation. K i values are reported as mean ± SEM. Comparisons between data sharing the same superscript ( a, b, c, d, e ) are significantly different (p < 0.05).
K i values were higher for Ca uptake than for enzymatic activ ity. Here we must consider that CaATPase activity was measured in the presence of calcimycin and calcium uptake in its absence, and that the relative distributions of the intermediate species of the cycle during the steady state of the reactions were different under both conditions (Takara et al., 2005) . Because the enzyme undergoes conformational changes along the cycle, one could expect that any inhibitor displays different affinities for the differ ent enzymatic conformations, and therefore, any change in the relative distributions of the conformers must affect the K i (app) of the inhibitor. The simulations of the behavior of the model under conditions reproducing the experimental results support the pro posal of the interaction of the anesthetics with the E2 species.
The bupivacaine K i for calcium uptake was significantly higher than for lidocaine. We attributed it to their different chemical structures: The bupivacaine molecule has an Nbutyl piperidine group, which gives the molecule higher molar relative mass, size, and steric impediment. Ropivacaine has an Npropyl piperidine group, and this difference from bupivacaine was associated with different myotoxicities (Zink et al., 2003) .
For diethylstilbestrol and ritodrine, the inhibition of the enzyme decreased upon increases in the protein concentration in the reaction medium. This was attributed to drug partitioning into the lipid bilayer. The inhibition of CaATPase by lidocaine and bupivacaine did not depend on the protein concentration. This is consistent with a moderate octanol/water partition coef ficient (Courtney, 1980; Leo, 1991) .
Lidocaine and bupivacaine K i in masticatory muscles were lower than those in whitefast muscles (Suko et al., 1976; Wolosker et al., 1992; Takara et al., 2000 Takara et al., , 2005 , indicating a higher affinity of the anesthetics for the CaATPase from masti catory muscles. Previous assumptions on the presence of a dif ferent type of isoform in masticatory muscles (Sánchez et al., 2004) could explain this fact. The study of partial reactions of the CaATPase cycle permits us to elucidate the actions of different compounds on this enzyme. The experiments where the enzyme was preincubated in 45 Ca, with ATP, EGTA, and lidocaine or bupivacaine added later, reflect only the transport of Ca already bound to the enzyme through the first 3 steps of the cycle. Our results showed that Ca binding to the transport sites (step 1) was not affected by lidocaine, and this result might also indicate that lidocaine does not affect step 3. Because Ca transport depends on ATP concen tration, but ATP does not relieve the inhibitory effect of the anesthetic, the results indicate that the partial reaction affected is the transfer of phosphate from ATP to the enzyme. In contrast, several authors reported a higher affinity of local anesthetics for the E2 conformers and a marked inhibition of phosphorylation through the reversal of step 4 (Suko et al., 1976; Wolosker et al., 1992; Takara et al., 2000 Takara et al., , 2005 , and the results of the simula tions also support a larger interaction of these drugs with the E2 conformers. Taking both groups of results together, we conclude that lidocaine and bupivacaine affect both the phosphorylation/ dephosphorylation steps (2 and 4) of the cycle.
Our results showed that lidocaine and bupivacaine, at con centrations present in dental cartridges, inhibit the sarcoplasmic reticulum CaATPase in masseter and medial pterygoid muscles. Although the inhibition of the CaATPase could not fully explain their myotoxic effects, the interaction between the anes thetics and the protein might induce masticatory muscle con traction and eventual rigidity.
